Ms. Toju Ogunremi started her career at the University of Saskatchewan, Canada where she conducted health and life science research using synchrotron technology. Her expertise is in the field of microbiology, biotechnology, infection prevention and control, guideline development, systematic reviews and critical appraisal of evidence to inform federal government policy.
Ms. Ogunremi has over 14 years of experience in scientific evidence reviews, critical appraisals, development of evidence-based guidelines, and stakeholder engagements, consultations and collaborations nationally and internationally. As past Executive Secretary for the Public Health Agency of Canada (PHAC)’s National Advisory Committee on Infection Prevention and Control (NAC-IPC) and manager of the Healthcare-Associated Infections Prevention and Control (HAIPC) Section, she led the development of national infection control guidelines for Canadian healthcare settings, with focus on HAIs, antimicrobial resistant organisms, and emerging infections – including H1N1, Ebola and COVID-19.
Ms Ogunremi is currently the Manager of the Knowledge Creation and Synthesis section of the Public Health Measures Guidance Division at PHAC. The section focuses on generating, appraising and synthesizing evidence on non-pharmaceutical public health measures to inform guidance. She currently serves as Vice-Chair of the Guidelines Collaboration Working Group for the Guidelines International Network (GIN).